HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
K V Toyka Selected Research
K V Toyka Research Topics
Disease
17
Multiple Sclerosis
02/2012 - 01/2000
8
Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
08/2005 - 02/2000
7
Experimental Autoimmune Neuritis
12/2002 - 05/2000
5
Autoimmune Diseases (Autoimmune Disease)
10/2005 - 02/2000
4
Disease Progression
01/2004 - 02/2000
4
Necrosis
01/2003 - 02/2000
4
Inflammation (Inflammations)
06/2001 - 04/2000
3
Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
10/2010 - 06/2000
3
Pain (Aches)
06/2010 - 06/2001
3
Myasthenia Gravis
12/2009 - 01/2001
3
Guillain-Barre Syndrome
04/2003 - 01/2001
3
Polymyositis
02/2002 - 01/2001
3
Autoimmune Diseases of the Nervous System
07/2001 - 05/2000
2
Stiff-Person Syndrome (Stiff Man Syndrome)
10/2009 - 07/2003
2
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
12/2003 - 09/2000
2
Brain Diseases (Brain Disorder)
07/2003 - 06/2000
2
Muscle Weakness
04/2003 - 05/2002
2
Human Influenza (Influenza)
06/2002 - 04/2001
2
Hyperalgesia
09/2001 - 06/2001
2
Miller Fisher Syndrome (Fisher Syndrome)
03/2001 - 01/2001
2
Demyelinating Diseases (Demyelinating Disease)
01/2001 - 10/2000
1
Psoriasis (Pustulosis Palmaris et Plantaris)
02/2012
1
Progressive Multifocal Leukoencephalopathy
02/2012
1
Small Fiber Neuropathy
06/2010
1
Thymoma (Thymic Carcinoma)
12/2009
1
Communicable Diseases (Infectious Diseases)
09/2009
1
Encephalomyelitis (Myeloencephalitis)
08/2005
1
Chronic Progressive Multiple Sclerosis
05/2005
1
Neoplasms (Cancer)
01/2004
1
Cardiotoxicity
01/2004
1
Ocular Motility Disorders (Convergence Insufficiency)
07/2003
1
Myotonic Dystrophy (Dystrophia Myotonica)
02/2003
1
Fatigue
12/2002
1
Tetanus
06/2002
1
Ankylosing Spondylitis
02/2002
1
Body Weight (Weight, Body)
02/2002
1
Ulcerative Colitis
02/2002
Drug/Important Bio-Agent (IBA)
10
Cytokines
IBA
06/2010 - 02/2000
8
Proteins (Proteins, Gene)
FDA Link
10/2009 - 09/2000
7
Antibodies
IBA
10/2010 - 01/2001
6
Messenger RNA (mRNA)
IBA
01/2003 - 02/2000
6
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
06/2001 - 02/2000
5
Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)
IBA
08/2005 - 04/2000
4
Immunoglobulin G (IgG)
IBA
10/2009 - 01/2001
4
Interferon-gamma (Interferon, gamma)
IBA
10/2005 - 10/2000
4
Mitoxantrone (Novantrone)
FDA Link
Generic
01/2005 - 01/2000
4
Antigens
IBA
02/2002 - 05/2000
3
Neutralizing Antibodies
IBA
02/2012 - 05/2000
3
Autoantigens
IBA
11/2001 - 02/2000
3
Methylprednisolone
FDA Link
Generic
08/2001 - 07/2000
2
Autoantibodies
IBA
10/2010 - 10/2009
2
Epitopes
IBA
10/2010 - 11/2001
2
amphiphysin
IBA
10/2009 - 07/2003
2
Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)
IBA
08/2005 - 03/2001
2
Interferon beta-1b (Betaseron)
FDA Link
05/2005 - 02/2001
2
Pharmaceutical Preparations
IBA
01/2005 - 01/2004
2
Chemokines
IBA
07/2004 - 10/2000
2
Metalloproteases (Metalloproteinases)
IBA
01/2004 - 02/2001
2
Matrix Metalloproteinase 9 (Gelatinase B)
IBA
12/2003 - 02/2001
2
Myelin Basic Protein
IBA
01/2003 - 04/2001
2
Mycophenolic Acid (Cellcept)
FDA Link
Generic
02/2002 - 01/2001
2
Interferon-beta
IBA
07/2001 - 02/2001
2
Myelin Proteins
IBA
04/2001 - 05/2000
2
Interleukin-10 (Interleukin 10)
IBA
12/2000 - 04/2000
1
Monoclonal Antibodies
IBA
02/2012
1
efalizumab (Raptiva)
FDA Link
02/2012
1
Myelin-Oligodendrocyte Glycoprotein
IBA
10/2010
1
Interleukin-2 (IL2)
IBA
12/2009
1
gamma-Aminobutyric Acid (GABA)
IBA
10/2009
1
anti-amphiphysin autoantibody
IBA
10/2009
1
Calcium
IBA
10/2009
1
Toll-Like Receptors (Toll-Like Receptor)
IBA
09/2009
1
Serotonin (5 Hydroxytryptamine)
IBA
10/2005
1
Cell Adhesion Molecules
IBA
08/2005
1
Toll-Like Receptor 4
IBA
08/2005
1
Prednisone (Sone)
FDA Link
Generic
04/2005
1
Adrenocorticotropic Hormone (ACTH)
FDA Link
04/2005
1
Adrenal Cortex Hormones (Corticosteroids)
IBA
04/2005
1
Chemokine CCL2 (Monocyte Chemoattractant Protein 1)
IBA
07/2004
1
Anthracyclines
IBA
01/2004
1
Chelating Agents
IBA
01/2004
1
Iron
IBA
01/2004
1
Propane
IBA
01/2004
1
Dexrazoxane (Zinecard)
FDA Link
Generic
01/2004
1
Intravenous Immunoglobulins (IVIG)
FDA Link
12/2003
1
Nicotinic Receptors (Nicotinic Acetylcholine Receptor)
IBA
04/2003
1
Creatine
IBA
02/2003
1
Interleukin-4 (Interleukin 4)
IBA
01/2003
1
Nerve Growth Factor (NGF)
IBA
01/2003
1
Nerve Growth Factors (Neurotrophins)
IBA
01/2003
1
Brain-Derived Neurotrophic Factor (BDNF)
IBA
01/2003
1
Interleukins
IBA
01/2003
1
Transforming Growth Factor beta (TGF-beta)
IBA
01/2003
1
Vaccines
IBA
06/2002
1
Adenosine Triphosphate (ATP)
IBA
05/2002
1
Peptides (Polypeptides)
IBA
11/2001
Therapy/Procedure
14
Therapeutics
10/2010 - 05/2000
5
Immunotherapy
11/2004 - 01/2000
1
Immunomodulation
01/2006
1
Glycemic Control
12/2003